CN119524140A - 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法 - Google Patents

预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法 Download PDF

Info

Publication number
CN119524140A
CN119524140A CN202411541425.3A CN202411541425A CN119524140A CN 119524140 A CN119524140 A CN 119524140A CN 202411541425 A CN202411541425 A CN 202411541425A CN 119524140 A CN119524140 A CN 119524140A
Authority
CN
China
Prior art keywords
combination
mannitol
eriodictyol
pancreas
sucralose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202411541425.3A
Other languages
English (en)
Chinese (zh)
Inventor
胡幼圃
何欣恬
吴永恩
唐熙卉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yage Biological Tech Co ltd
Original Assignee
Yage Biological Tech Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yage Biological Tech Co ltd filed Critical Yage Biological Tech Co ltd
Publication of CN119524140A publication Critical patent/CN119524140A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN202411541425.3A 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法 Pending CN119524140A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562257707P 2015-11-19 2015-11-19
US62/257,707 2015-11-19
PCT/CN2016/106607 WO2017084631A1 (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
CN201680067605.XA CN109715170A (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680067605.XA Division CN109715170A (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法

Publications (1)

Publication Number Publication Date
CN119524140A true CN119524140A (zh) 2025-02-28

Family

ID=58717399

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202411541425.3A Pending CN119524140A (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
CN201680067605.XA Pending CN109715170A (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
CN202411541590.9A Pending CN119424472A (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201680067605.XA Pending CN109715170A (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
CN202411541590.9A Pending CN119424472A (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法

Country Status (12)

Country Link
US (1) US20180325840A1 (cg-RX-API-DMAC7.html)
EP (1) EP3378481B1 (cg-RX-API-DMAC7.html)
JP (1) JP6914256B2 (cg-RX-API-DMAC7.html)
CN (3) CN119524140A (cg-RX-API-DMAC7.html)
DK (1) DK3378481T3 (cg-RX-API-DMAC7.html)
ES (1) ES2949047T3 (cg-RX-API-DMAC7.html)
FI (1) FI3378481T3 (cg-RX-API-DMAC7.html)
HU (1) HUE062181T2 (cg-RX-API-DMAC7.html)
PL (1) PL3378481T3 (cg-RX-API-DMAC7.html)
PT (1) PT3378481T (cg-RX-API-DMAC7.html)
TW (1) TWI797068B (cg-RX-API-DMAC7.html)
WO (1) WO2017084631A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110269855A (zh) * 2019-07-19 2019-09-24 辽宁大学 黄酮类小分子化合物在制备抑制胰脂肪酶活性药物中的应用
JP2021161070A (ja) * 2020-03-31 2021-10-11 花王株式会社 Glp−1分泌促進剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
CN1840518A (zh) * 2005-08-18 2006-10-04 山东寻山水产集团有限公司 一种从海带中提取甘露醇的方法
JP2008007452A (ja) * 2006-06-28 2008-01-17 Ajinomoto Co Inc 膵β細胞保護剤
CN1911114B (zh) * 2006-08-25 2012-08-15 李罡 一种含三氯蔗糖的饮料
EP1925311A1 (en) * 2006-11-15 2008-05-28 Melbrosin International Produktions und Vertriebs GmbH & Co KG Use of a plant extract or plant juice
JP5327732B2 (ja) * 2007-08-31 2013-10-30 広島県 α−グルコシダーゼ阻害剤及びその製造方法
JPWO2010044371A1 (ja) * 2008-10-16 2012-03-15 国立大学法人群馬大学 インスリン分泌促進剤
ES2597955T3 (es) * 2009-02-11 2017-01-24 Ramot At Tel-Aviv University Ltd. Composiciones antisépticas que comprenden iones de plata y mentol y usos de las mismas
IT1396074B1 (it) * 2009-10-12 2012-11-09 Axioma S R L Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'
EP2559346B1 (en) * 2011-08-15 2014-03-26 Symrise AG Oleanene-type triterpene glycosides as masking agents
CN102920683B (zh) * 2012-06-11 2013-08-14 江苏豪森药业股份有限公司 奥氮平口腔速溶膜
CN104490611B (zh) * 2014-12-12 2017-08-08 安徽新华学院 一种天然养发泡腾颗粒或泡腾片及其制备方法

Also Published As

Publication number Publication date
WO2017084631A1 (zh) 2017-05-26
FI3378481T3 (fi) 2023-07-06
CN109715170A (zh) 2019-05-03
CN119424472A (zh) 2025-02-14
HUE062181T2 (hu) 2023-09-28
JP2019511996A (ja) 2019-05-09
WO2017084631A9 (zh) 2019-01-17
TW201720461A (zh) 2017-06-16
EP3378481A4 (en) 2019-07-10
US20180325840A1 (en) 2018-11-15
PT3378481T (pt) 2023-06-28
ES2949047T3 (es) 2023-09-25
DK3378481T3 (da) 2023-07-03
EP3378481A1 (en) 2018-09-26
PL3378481T3 (pl) 2023-12-27
TWI797068B (zh) 2023-04-01
JP6914256B2 (ja) 2021-08-04
WO2017084631A8 (zh) 2018-09-13
EP3378481B1 (en) 2023-04-05

Similar Documents

Publication Publication Date Title
US9034397B2 (en) Method for treating obesity
TWI678211B (zh) 管花肉蓯蓉萃取物及異類葉升麻苷於保護肌肉之用途
WO2021143912A1 (zh) 无细胞脂肪提取液对脂肪肝及其并发症的治疗作用
JP6211689B2 (ja) 血糖を調節するための薬剤
JP6622420B2 (ja) ピニトール、d−カイロ−イノシトール、またはこれらの類似化合物を有効成分として含む月経前症候群の改善、予防、または治療用組成物
WO2013087023A1 (zh) 一种天然减肥保健组合物及其应用
CN119424472A (zh) 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
US10149880B2 (en) Feijoa fruit extract
KR101206543B1 (ko) 율피 추출물을 포함하는 지방간의 예방 또는 치료용 조성물
KR100473530B1 (ko) 소풍순기원 생약 복합제 추출물을 함유하는 당뇨병 예방및 치료를 위한 조성물
US7875300B2 (en) Methods for reducing circulating glucose levels
CN108379495B (zh) 高良姜提取物在制备预防和/或治疗非酒精性脂肪肝制剂中的用途
KR100473531B1 (ko) 변방 소풍순기원 생약 복합제 추출물을 함유하는 당뇨병예방 및 치료를 위한 조성물
Misra et al. Antihypertensive (Blood Pressure Lowering) effects of Stevioside, from Stevia rebaudianaBertoni, on rats, dogs and humans–A short review
US11096903B2 (en) Use of pinocarveol
JP2015078140A (ja) アルコール性脂肪肝予防・治療剤
KR20190100878A (ko) 생강나무 잎 추출물을 유효성분으로 포함하는 비만 또는 비만 관련 합병증의 예방, 치료, 또는 개선용 조성물
Kakunuri et al. Panax ginseng: the medicinal herb
CN102114076A (zh) 肉桂提取物的制备方法、肉桂提取物、其组合物以及用途
Boggula et al. A novel approach for the treatment of diabetes mellitus: A review of Ocimum sp.
CN118340803A (zh) 一种杉叶醇提取物在制备治疗糖尿病药物中的应用
KR20170064023A (ko) 돼지감자 추출물을 함유하는 췌장베타세포 손상을 예방, 개선 또는 치료를 위한 조성물
CN102641341B (zh) 一种治疗肾病的中药提取物及其制备方法
WO2020026182A1 (en) Composition containing chromium, extract of a plant of the morus genus and extract of a plant of the ilex genus for the prevention and treatment of prediabetes and relative pharmaceutical and nutraceutical compositions
KR20150055456A (ko) 백강잠 추출물을 포함하는 당뇨병 및 당뇨병성 합병증 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination